The Dynamics of Glutathione Species and Ophthalmate Concentrations in Plasma from the VX2 Rabbit Model of Secondary Liver Tumors
Open Access
- 17 February 2011
- journal article
- research article
- Published by Wiley in HPB Surgery
- Vol. 2011, 1-8
Abstract
Purpose. Available tumor markers have low sensitivity/specificity for the diagnosis of liver tumors. The present study was designed to evaluate the oxidoreductive status of the liver as surrogates of tumor subsistence and growth.Methods. Glutathione species (GSH:GSSG), ophthalmate (OA) concentrations, and their turnover were measured in plasma of rabbits () in their healthy state and in the state of tumor growth after implantation of the VX2 carcinoma in their liver. Tumors were allowed to grow for a period of 14 days when rabbits were sacrificed. Livers were removed and cysteine concentration was measured in liver tissue.Results. Tumor growth was found in 100% of the rabbits. Concentration and labeling of GSH/GSSG were similar in experimental animals before and after tumor implantation and to sham animals. In contrast, OA concentration increased significantly in experimental animals after tumor implantation when compared to same animals prior to tumor implantation and to sham animals (). The concentration of cysteine, a precursor of GSH, was found to be significantly lower in the liver tissue adjacent to the tumor ().Conclusion. Disturbances in the oxidoreductive state of livers appear to be a surrogate of early tumor growth.
Keywords
Funding Information
- National Institutes of Health (5R33DK070291, 1R01ES013925)
- National Institutes of Health (5R33DK070291, 1R01ES013925)
This publication has 27 references indexed in Scilit:
- Intraprocedural diffusion‐weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumorsJournal of Magnetic Resonance Imaging, 2009
- Dynamics of glutathione and ophthalmate traced with2H-enriched body water in rats and humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Targeting of VX2 Rabbit Liver Tumor by Selective Delivery of 3-Bromopyruvate: A Biodistribution and Survival StudyThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Combined radiofrequency ablation and doxorubicin‐eluting polymer implants for liver cancer treatmentJournal of Biomedical Materials Research Part A, 2006
- Serum and Bile Markers for CholangiocarcinomaSeminars in Liver Disease, 2004
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Oxidative DNA base damage and antioxidant enzyme activities in human lung cancerFEBS Letters, 1994
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosisJournal of Hepatology, 1994
- Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinomaHepatology, 1994
- EXPERIMENTS ON THE CAUSE OF THE RABBIT CARCINOMAS DERIVED FROM VIRUS-INDUCED PAPILLOMASJournal of Experimental Medicine, 1952